Ngb-2849

HCID 15411150CAS 197242-80-1

Basic information

Standard SMILES
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2cc3ccccc3cc2c1
InChIKey
ZITQUAHPZJHCJH-UHFFFAOYSA-N
Molecular formula
C29H29Cl2N3O
Average molar mass
506.5 g/mol

Overview

a dopamine D3 receptor antagonist; structure in first source

Names & identifiers

Preferred name
Ngb-2849
IUPAC
N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]anthracene-2-carboxamide

Names & synonyms

NGB284926P8N956NZNGB-2849197242-80-1RefChem:927696NGB 2849UNII-26P8N956NZN-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyl)-2-anthracenecarboxamide2-Anthracenecarboxamide, N-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyl)-N-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyl}-2-anthracenecarboxamideorb1739455SCHEMBL8183795
Show more names
ZITQUAHPZJHCJH-UHFFFAOYSA-N

Database identifiers

CAS
197242-80-1
PubChem CID
15411150
UNII
26P8N956NZ
Nikkaji
J959.637B

Properties

Computed structural properties

XLogP
7
Topological polar surface area
35.6 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
7
Heavy atoms
35

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 1 item

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.

Related reactions

4 records

Linked notes

Loading…